Compare INGR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGR | GRFS |
|---|---|---|
| Founded | 1906 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.8B |
| IPO Year | 1997 | N/A |
| Metric | INGR | GRFS |
|---|---|---|
| Price | $111.91 | $7.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $133.00 | $10.15 |
| AVG Volume (30 Days) | 535.9K | ★ 817.0K |
| Earning Date | 05-05-2026 | 07-28-2022 |
| Dividend Yield | ★ 2.93% | 1.87% |
| EPS Growth | ★ 15.14 | N/A |
| EPS | ★ 11.18 | N/A |
| Revenue | ★ $7,219,000,000.00 | N/A |
| Revenue This Year | $3.93 | $5.33 |
| Revenue Next Year | $2.79 | $6.50 |
| P/E Ratio | ★ $10.01 | $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $102.31 | $6.19 |
| 52 Week High | $141.78 | $11.14 |
| Indicator | INGR | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 30.68 |
| Support Level | $109.25 | N/A |
| Resistance Level | $114.10 | $9.11 |
| Average True Range (ATR) | 2.24 | 0.19 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 59.83 | 10.80 |
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.